Featured Research

from universities, journals, and other organizations

Study To Determine Effectiveness Of Multidisciplinary Treatment At National Jewish

Date:
November 2, 1999
Source:
National Jewish Medical And Research Center
Summary:
A Pediatric Outcomes Study is currently underway at National Jewish to investigate how a multidisciplinary treatment approach can minimize the effects of chronic respiratory and immunological illnesses on affected children and their families.

DENVER - A Pediatric Outcomes Study is currently underway at National Jewish Medical and Research Center to investigate how a multidisciplinary treatment approach can minimize the effects of chronic respiratory and immunological illnesses on affected children and their families.

Related Articles


Chronic, out-of-control respiratory or immune system illnesses impact every aspect of a child’s life. Children who have respiratory or immunological illnesses, such as allergies, atopic dermatitis or vocal cord dysfunction, experience hospital emergency room visits, absences from school and a limitation on activities. The families of these children also bear a great burden, both economically and psychologically. Previous studies have focused on the outcome of children with chronic asthma.

The new study conducted by Mary Klinnert, Ph.D., Donna Bratton, M.D., and Dan Atkins, M.D., will involve 100 pediatric patients who have respiratory and immunological illnesses other than asthma. These illnesses include food allergies, atopic dermatitis and vocal cord dysfunction.

Patients selected for the Pediatric Outcomes Study will participate in either the Pediatric Day Treatment Program or the Pediatric Outpatient Program at National Jewish. Patients will be monitored for two years following their treatment to determine the effectiveness of involvement in either of these multidisciplinary programs.

“We want to determine how we are helpful to kids that come through National Jewish with either asthma or the other illnesses we treat,” says Dr. Klinnert, a psychologist in the Department of Pediatrics. “We want to see how these treatment programs result in better physical functioning, better health care utilization and improved quality of life.”

Improved quality of life is measured by criteria such as fewer limitations on activities, less anxiety and greater emotional stability.

For the Pediatrics Outcomes Study, Dr. Klinnert notes, “Children with atopic dermatitis are of particular interest to us.” Atopic dermatitis includes environmentally-linked skin disorders such as eczema. “Little information is available regarding the psychosocial characteristics of the families of these children, or of the effectiveness of multidisciplinary interventions in bringing the illness under control,” Dr. Klinnert adds.

The new Pediatric Outcomes Study is a successor to a Pediatric Asthma Outcomes Study initiated in 1998 that focuses on asthma patients. The preliminary indications for the Asthma Outcomes Study have been extremely positive. “We’ve seen a great decrease in the frequency and severity of symptoms such as wheezing, coughing and shortness of breath. Health care spending also decreased dramatically and quality of life improved,” Dr. Klinnert notes.

Before participating in the Pediatric Asthma Outcomes Study, a typical child required frequent hospital visits and medication. One year after the program, patients were significantly better, and the average yearly medical costs per child dropped 89 percent, from $16,000 to $1,800. These savings appear to be sustained through the second year of the study. Preliminary findings indicate that the asthmatic children used 53 percent less steroid medication in the two years following their participation in the study. “This is especially important,” Dr. Klinnert says, “since kids who use steroids can suffer side effects including suppressed growth, weight gain, weakened bones, high blood pressure and cataracts.”

The new Pediatric Outcomes Study builds upon and extends the Asthma Outcomes Study. Both studies are funded by the Scholl Foundation.

National Jewish conducts additional, unrelated outcomes studies on its patients.

The Number 1 Respiratory Hospital in the U.S. for Two Consecutive Years, U.S. News & World Report, 1998-2000.


Story Source:

The above story is based on materials provided by National Jewish Medical And Research Center. Note: Materials may be edited for content and length.


Cite This Page:

National Jewish Medical And Research Center. "Study To Determine Effectiveness Of Multidisciplinary Treatment At National Jewish." ScienceDaily. ScienceDaily, 2 November 1999. <www.sciencedaily.com/releases/1999/11/991101172808.htm>.
National Jewish Medical And Research Center. (1999, November 2). Study To Determine Effectiveness Of Multidisciplinary Treatment At National Jewish. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/1999/11/991101172808.htm
National Jewish Medical And Research Center. "Study To Determine Effectiveness Of Multidisciplinary Treatment At National Jewish." ScienceDaily. www.sciencedaily.com/releases/1999/11/991101172808.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com
Madagascar Working to Contain Plague Outbreak

Madagascar Working to Contain Plague Outbreak

AFP (Nov. 24, 2014) Madagascar said Monday it is trying to contain an outbreak of plague -- similar to the Black Death that swept Medieval Europe -- that has killed 40 people and is spreading to the capital Antananarivo. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins